China Proposes to Tighten Biosecurity Law and its Potential Impact on Foreign Pharmaceutical and Biotech Companies Operating in China
Betty L. Louie is a partner of the M&A and Private Equity Group based in the Beijing office. With a particular expertise on Asia outbound investments, Betty has extensive experience in the areas of mergers and acquisitions, private equity, strategic investments and capital markets. She has practiced for over 20 years on the continents – the US, Europe and China – on strategic and complex mergers and acquisitions.
She regularly advises Chinese corporations and financial institutions investing and operating outside of China, and also assists international companies with their FDIs in China. She also advises global private equity and venture capital funds on their investments in Chinese companies, as well as assisting international tech companies on their structuring and operations in China.
Since 2012, she has been consistently recognized and ranked in legal industry publications, such as Chambers Global, Chambers Asia Pacific and Milano Finanza. Clients have praised Betty as “extremely experienced with complex legal issues, both M&A and regulatory issues”, “highly experienced in helping Chinese companies and investors carry out transactions,” “having a specialist knowledge of the Chinese market” and “offers practical and efficient solutions.”
In addition, Betty also represents a broad range of foreign investors (U.S., Middle Eastern, European) in connection with their global investments and acquisitions.
She advises companies in various industries, including energy, technology, financial services, healthcare, medical devices, real estate and advanced manufacturing.
Before relocating to China, Betty practiced in New York for more than 10 years, and also practiced in Italy for close to 10 years.
April.10.2019 - April.11.2019
April.25.2018 - April.26.2018